Company intelligence / Profile preview
Neurelis
San Diego, California, USAneurelis.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Neurelis is focused on developing treatments for neurological conditions, with a commercial product like VALTOCO® for epilepsy and several pipeline candidates.
- Therapeutic areas
- ImmunologyPsychiatryNeurology
- Modalities
- Small moleculestherapeutic proteinspeptidesnon-peptide macromolecules
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Partnerships with companies like China Medical System and AculysPharma for product distribution outside the US.
Beyond the preview
Go deeper on Neurelis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neurelis.